ESG8 May 2026, 01:14 pm
Emcure Pharma Receives ESG Rating of 21 from NSE
AI Summary
Emcure Pharmaceuticals Ltd has been assigned an ESG rating of 21 by NSE Sustainability Ratings & Analytics Limited for the financial year 2024-25. The rating, based on publicly available information, was communicated to Emcure via email on May 7, 2026. This disclosure is made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- NSE Sustainability Ratings & Analytics assigned Emcure an ESG rating of 21.
- The ESG rating is for the financial year 2024-25.
- The rating is based on publicly available information.
- Emcure received notification of the rating on May 7, 2026.
Price Impact
More from EMCURE